Stroke Trial, Recruiting NCT05024292 Sponsor: Shanghai Jiao Tong University Affiliated Sixth People's Hospital Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT05024292
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between 18 and 95 years of age who have had a blockage in a specific artery in the brain (the internal carotid artery or a main branch of the middle cerebral artery).
  • People whose stroke symptoms were measured as moderately severe or worse on a standard stroke scale (a score of at least 6 on the NIHSS) at the time of hospital admission, and who had little to no disability before the stroke occurred (a score of 0 or 1 on the modified Rankin scale).
  • People whose brain scan shows that a large enough portion of the brain tissue is still potentially salvageable, based on a standard scoring system called ASPECTS (a score of at least 6).
  • People who had a specific set of brain imaging scans — including a standard CT scan, a CT scan of the blood vessels, and a CT scan measuring blood flow — all performed at the hospital running the trial.
  • People in whom blood flow to the affected artery was successfully restored to a good level (a score of 2b to 3 on the mTICI scale) after the clot removal procedure.

Who may not be able to join:

  • People whose stroke was caused by a build-up of fatty deposits in a large artery, a tear in an artery wall, or other identified causes — or where there are blockages in two connected arteries at the same time (tandem occlusion).
  • People who required additional procedures such as balloon widening of an artery (angioplasty) or placement of a small tube to keep the artery open (stenting) after the clot removal procedure.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Yueqi Zhu, PhD, Shanghai Jiao Tong University Affiliated Sixth People's Hospital

Phone: +86-21-18930177565

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Registry
ClinicalTrials.gov
Start date
1 January 2022
Est. completion
1 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

functional independence

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov